UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Leukemia, 2017-11, Vol.31 (11), p.2398-2406

2017

Link zum Volltext

Verfügbarkeit prüfen

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

Leukemia, 2016-06, Vol.30 (6), p.1230-1236

2016

Link zum Volltext

Verfügbarkeit prüfen

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia

Leukemia, 2016-08, Vol.30 (8), p.1781-1784

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.410-415

2014

Link zum Volltext

Verfügbarkeit prüfen

Angiosarcoma of bone marrow with unusual expression of chymase: diagnosis in a trephine biopsy specimen

Journal of clinical pathology, 2007-10, Vol.60 (10), p.1183-1183

2007

Link zum Volltext

Verfügbarkeit prüfen

Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause

Thrombosis and haemostasis, 1985, Vol.54 (2), p.475

1985

Link zum Volltext

Verfügbarkeit prüfen

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Leukemia, 2020-10, Vol.34 (10), p.2823-2823

2020

Link zum Volltext

Verfügbarkeit prüfen

Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

Journal of clinical oncology, 2003-01, Vol.21 (2), p.256-265

2003

Link zum Volltext

Verfügbarkeit prüfen

9210 Bendamustine vs. fludarabine as second-line treatment in chronic lymphocytic leukemia

European journal of cancer supplements, 2009, Vol.7 (2), p.563-563

2009

Link zum Volltext

Verfügbarkeit prüfen

Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia

Annals of hematology, 2002-10, Vol.81 (10), p.570-574

2002

Link zum Volltext

Verfügbarkeit prüfen

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

Leukemia, 2009-12, Vol.23 (12), p.2248-2258

2009

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte-Rich Classical Hodgkin's Lymphoma: Clinical Presentation and Treatment Outcome in 100 Patients Treated Within German Hodgkin's Study Group Trials

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5739-5745

2005

Link zum Volltext

Verfügbarkeit prüfen

High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma

Annals of oncology, 2010-11, Vol.21 (11), p.2255-2261

2010

Link zum Volltext

Verfügbarkeit prüfen

Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder

Blood, 1988-04, Vol.71 (4), p.1074-1078

1988

Link zum Volltext

Verfügbarkeit prüfen

Subgroup specific therapy effects in AML: AMLCG data

Annals of hematology, 2004, Vol.83 Suppl 1, p.S100-S101

2004

Link zum Volltext

Verfügbarkeit prüfen

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

Annals of hematology, 2012-07, Vol.91 (7), p.1051-1063

2012

Link zum Volltext

Verfügbarkeit prüfen

Treatment of older patients with AML

Critical reviews in oncology/hematology, 2005-11, Vol.56 (2), p.247-259

2005

Link zum Volltext

Verfügbarkeit prüfen

Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population--II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions

Thrombosis and haemostasis, 1985, Vol.54 (3), p.721

1985

Link zum Volltext

Verfügbarkeit prüfen

COAGULATION FACTORS AND THE PROGRESS OF CORONARY HEART DISEASE

The Lancet (British edition), 1987-08, Vol.330 (8556), p.461-461

1987

Link zum Volltext

Verfügbarkeit prüfen

S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes

Annals of hematology, 1997-05, Vol.74 (5), p.205-208

1997

Link zum Volltext

Verfügbarkeit prüfen

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

Arteriosclerosis and thrombosis, 1994-01, Vol.14 (1), p.54

1994

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow Mastocytosis Associated with IgM Kappa Plasma Cell Myeloma

Leukemia & lymphoma, 2004-04, Vol.45 (4), p.801-805

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(85)
Reviews
(3)
Berichte
(1)

Sprache

Englisch
(73)
Deutsch
(17)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(63)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Middle Aged
(36)
Adult
(33)
Aged
(27)
Male
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Biological And Medical Sciences
(26)
Female
(26)
Hematology
(24)
Medical Sciences
(23)
Oncology
(21)
Adolescent
(18)
Cytarabine - Administration & Dosage
(13)
Age Factors
(12)
Hematologic And Hematopoietic Diseases
(12)
Treatment Outcome
(12)
Leukemia, Myeloid, Acute - Drug Therapy
(10)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

Angiosarcoma of bone marrow with unusual expression of chymase: diagnosis in a trephine biopsy specimen

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid Leukemia

Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

9210 Bendamustine vs. fludarabine as second-line treatment in chronic lymphocytic leukemia

Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation

Lymphocyte-Rich Classical Hodgkin's Lymphoma: Clinical Presentation and Treatment Outcome in 100 Patients Treated Within German Hodgkin's Study Group Trials

High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma

Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder

Subgroup specific therapy effects in AML: AMLCG data

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

Treatment of older patients with AML

Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population--II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions

COAGULATION FACTORS AND THE PROGRESS OF CORONARY HEART DISEASE

S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

Bone Marrow Mastocytosis Associated with IgM Kappa Plasma Cell Myeloma

Suchergebnisse filtern